Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma

Bone Marrow Transplantation

Volumn 21, Issue 7, 1998, Pages 725-726

  Moritake, H ^a   Ikuno, Y ^a   Tasaka, H ^a   Koga, H ^b   Miyazaki, S ^b   Okamura, J ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

AlloBMT; DLI; Rhabdomyosarcoma

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CASE REPORT; DISEASE COURSE; DONOR; DONOR LYMPHOCYTE INFUSION; HUMAN; INFUSION; LEUKOCYTE; MALE; PRIORITY JOURNAL; RELAPSE; RHABDOMYOSARCOMA; SALVAGE THERAPY; SCHOOL CHILD; TREATMENT FAILURE;

EID: 0031899188     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701150     Document Type: Article

References (11)

1. Ruymann FB, Newton WA, Ragag AH et al. Bone marrow metastasis at diagnosis in children and adolescents with rhabdomyosarcoma: a report from the intergroup rhabdomyosarcoma study. Cancer 1984; 82: 349-353.
2. Etcubanas E, Peiper S, Stass S et al. Rhabdomyosarcoma presenting as disseminated malignancy from an unknown primary site: a retrospective study of 10 pediatric cases. Med Pediatr Oncol 1989; 17: 39-44.
3. Sabattini E, Falini B, Pileri S. Rhabdomyosarcoma presenting as leukemia. Histopathol 1991; 19: 575-579.
4. Morandi S, Manna A, Sabattini E et al. Rhabdomyosarcoma presenting as acute leukemia. J Ped Hemat/Oncol 1996; 18: 305-307.
5. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 11: 133-138.
6. Horowitz MM, Gale RP. Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
7. Chan KW, Rogers PCJ, Fryer CJH. Breast metastases after bone marrow transplantation for rhabdomyosarcoma. Bone Marrow Transplant 1991; 7: 171-172.
8. Koscielniak E, Kingebiel TH, Peters C et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 1997; 19: 227-231.
9. Matthay KK, Seeger RC, Reynolds P et al. Allogeneic vs autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. J Clin Oncol 1994; 12: 2382-2389.
10. Ladenstein R, Lasset C, Hartmann O et al. Comparison of auto vs allografting as consolidation of primary treatments in advanced neuroblastoma over 1 year of age at diagnosis: reports from the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 37-46.
11. Slavin S, Naparstek E, Nagler A et al. Allogeneic therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.